CAPPED BONUSZERTIFIKAT - MERCK & CO. Stock

Certificat

DE000PN7M254

Delayed Deutsche Boerse AG 11:20:33 2024-06-12 am EDT
107.6 EUR -0.87% Intraday chart for CAPPED BONUSZERTIFIKAT - MERCK & CO.
Current month+1.55%
1 month+0.88%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-12 107.6 -0.87%
24-06-11 108.5 +0.18%
24-06-10 108.3 +0.45%
24-06-07 107.8 +0.79%
24-06-06 107 -0.07%

Delayed Quote Deutsche Boerse AG

Last update June 12, 2024 at 11:20 am EDT

More quotes

Static data

Product typeCertificats Bonus
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN7M25
ISINDE000PN7M254
Date issued 2023-08-22
Strike 120 $
Maturity 2024-12-20 (191 Days)
Parity 1 : 1
Emission price 93.15
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 108.7
Lowest since issue 93.6
Spread 0.02
Spread %0.02%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.8 USD
Average target price
142.7 USD
Spread / Average Target
+8.22%
Consensus